Institutional Ownership Axsome Therapeutics, Inc. (AXSM)
This table provides information about the institutional ownership of Axsome Therapeutics, Inc. (AXSM). We have compiled data on the 326 institutions that hold shares in the stock, with a total of 37.7 Million shares, which have been reported (via 13F filing form) to have a value of $3.71 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
101,422
shares
|
$10 Million
0.0% of portfolio
|
Q3 2024
Reduced 1.19%
|
|
Tri Locum Partners LP
New York, NY |
Nov 14, 2024 Q3 2024 |
91,721
shares
|
$9.05 Million
2.2% of portfolio
|
Q3 2024
Reduced 70.08%
|
|
Voya Investment Management LLC
Atlanta, GA |
Nov 14, 2024 Q3 2024 |
91,155
shares
|
$9 Million
0.01% of portfolio
|
Q3 2024
Added 2.52%
|
|
Artia Global Partners LP
Miami, FL |
Nov 14, 2024 Q3 2024 |
87,848
shares
|
$8.67 Million
2.15% of portfolio
|
Q2 2023
New holding
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
87,758
shares
|
$8.66 Million
0.0% of portfolio
|
Q3 2024
Added 9.42%
|
|
Lazard Asset Management LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
85,932
shares
|
$8.48 Million
0.01% of portfolio
|
Q3 2024
New holding
|
|
Cannell & Co.
New York, NY |
Feb 05, 2024 Q4 2023 |
82,845
shares
|
$8.18 Million
0.22% of portfolio
|
Q4 2023
Reduced 20.49%
|
|
Eagle Asset Management Inc
St Petersburg, FL |
Nov 12, 2024 Q3 2024 |
82,791
shares
|
$8.17 Million
0.04% of portfolio
|
Q3 2024
Reduced 16.07%
|
|
Spears Abacus Advisors LLC
|
Nov 12, 2024 Q3 2024 |
82,087
shares
|
$8.1 Million
0.16% of portfolio
|
Q3 2024
Reduced 0.01%
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
81,997
shares
|
$8.09 Million
0.05% of portfolio
|
Q3 2024
Added 39.19%
|
|
Privium Fund Management B.V.
|
Nov 01, 2024 Q3 2024 |
80,232
shares
|
$7.92 Million
1.8% of portfolio
|
Q3 2024
Added 7.94%
|
|
Neuberger Berman Group LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
80,014
shares
|
$7.9 Million
0.01% of portfolio
|
Q3 2024
Added 7.02%
|
|
Affinity Asset Advisors, LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
80,000
shares
|
$7.89 Million
1.24% of portfolio
|
Q2 2024
Reduced 42.76%
|
|
Morgan Jess S & CO Inc
|
Oct 21, 2022 Q3 2022 |
78,895
shares
|
$7.79 Million
3.06% of portfolio
|
Q3 2022
Reduced 24.78%
|
|
Act Capital Management, LLC
Wayne, PA |
Nov 03, 2022 Q3 2022 |
73,000
shares
|
$7.2 Million
4.5% of portfolio
|
Q3 2022
New holding
|
|
Peregrine Capital Management LLC
|
Oct 24, 2024 Q3 2024 |
71,929
shares
|
$7.1 Million
0.2% of portfolio
|
Q3 2024
Reduced 17.68%
|
|
Spider Rock Advisors, LLC
|
Nov 01, 2024 Q3 2024 |
65,008
shares
|
$6.41 Million
0.09% of portfolio
|
Q3 2024
Reduced 7.14%
|
|
Lindbrook Capital, LLC
|
Nov 01, 2024 Q3 2024 |
64,707
shares
|
$6.39 Million
0.49% of portfolio
|
Q3 2024
Reduced 7.99%
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
62,167
shares
|
$6.13 Million
0.01% of portfolio
|
Q3 2024
New holding
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
61,785
shares
|
$6.1 Million
0.0% of portfolio
|
Q3 2024
Added 279.61%
|
|
Moody Aldrich Partners LLC
|
Oct 22, 2024 Q3 2024 |
60,644
shares
|
$5.98 Million
1.08% of portfolio
|
Q3 2024
Reduced 1.79%
|
|
Swiss National Bank
Zurich, V8 |
Nov 07, 2024 Q3 2024 |
60,500
shares
|
$5.97 Million
0.0% of portfolio
|
Q4 2023
Reduced 15.62%
|
|
Scout Investments, Inc.
|
Nov 12, 2024 Q3 2024 |
59,878
shares
|
$5.91 Million
0.16% of portfolio
|
Q3 2024
Reduced 13.92%
|
|
Schroder Investment Management Group
London, X0 |
Nov 13, 2024 Q3 2024 |
58,300
shares
|
$5.75 Million
0.01% of portfolio
|
Q4 2023
New holding
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
58,300
shares
|
$5.75 Million
1.38% of portfolio
|
Q2 2023
New holding
|